Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

78 results about "Hereditary deafness" patented technology

Hereditary deafness is a condition that is passed to children from one or both parents through genetic makeup. The end result is hearing loss, which may or may not be present from birth.

Kit for detecting hereditary hearing loss

The invention brings forward a kit for detecting hereditary hearing loss. The kit provided by the invention comprises a primer combination and a probe combination of nine hereditary hearing loss polymorphic sites on GJB2(Cx26) gene, SLC26A4(PDS) gene and 12S rRNA(MTRNR1) gene, and can be used to accurately determine the wild type, homozygous mutation or heterzygosity of related sites and realize molecular diagnosis of hearing loss. With the application of the kit provided by the invention, detection can be carried out by cheap equipment or macroscopic observation. The primer combination, reagent panel and kit provided by the invention can be used for the screening of hereditary hearing loss to realize early detection, early prevention and prenatal guidance. The invention is of great commercial value and social significance.
Owner:BOAO BIOLOGICAL CO LTD +1

Hereditary hearing loss susceptible gene 20 site typing detection kit

The invention discloses a hereditary hearing loss susceptible gene 20 site typing detection kit. The kit comprises PCR amplification primers and single-base extension primers of 1494 C>T and 1555 A>G sites of a mitochondrial gene, 35dleG, 299-300delAT, 235delC, 176-191del19 and 167delT sites of a GJB2 gene, 547G>A and 538C>T sites of a GJB3 gene, and 281C>T, 589G>A, IVS7-2A>G, 1174A>T, 1226G>A, IVS15+5G>A, 1975G>C, 2027T>A, 2162C>T and 2168A>G sites of a SLC26A4 gene. The primers have sequences shown in the formulas of SEQ ID No: 1 to SEQ ID NO: 40. The kit is divided into two groups and is used for amplification and detection of 20 sites so that the accuracy of detection is guaranteed. The kit realizes high efficiency, low cost and high accuracy detection of a hereditary hearing loss susceptible gene type.
Owner:HANGZHOU JILUO BIOLOGICAL PHARMA CO LTD

Reconstructed oocyte of deaf model pig, construction method of reconstructed oocyte, deaf model pig, and construction method and application of deaf model pig

PendingCN110468154AAvoid phenotypic differencesReliable Large Animal ModelsCompounds screening/testingHydrolasesDiseaseEmbryo transfer
The invention discloses a reconstructed oocyte of a deaf model pig and a construction method of the reconstructed oocyte, and also discloses the deaf model pig and a construction method and application of the deaf model pig. According to the reconstructed oocyte of the deaf model pig, the construction method of the reconstructed oocyte and the construction method of the deaf model pig, by knockingout a pig OSBPL2 gene, the reconstructed oocyte of a deaf mini-pig is obtained, and in combination with a CRISPR/Cas9 gene editing technology, a somatic cell nuclear transfer technology and an embryotransfer technology, high efficiency and feasibility of the construction method for the genetically engineered deaf model pig are proven. Through the construction method of the deaf model pig, genotypes and deafness phenotypes of human OSBPL2 gene mutations can be precisely duplicated, the pig of which an OSBPL2 gene is knocked out has typical characteristics of human autosomal dominant hereditary hearing loss (DFNA67), therefore, a reliable big animal model can be provided for disease research of the human hereditary hearing loss, and the deaf model pig can be applied to inner-ear gene repairing, inner-ear hair cell regeneration, hearing reconstruction and the like.
Owner:NANJING MEDICAL UNIV +1

Deafness-related gene capture kit and application thereof

The invention discloses a deafness-related gene capture kit and an application thereof. The invention provides a capture probe. The capture probe is as shown in 1) or 2) which are described in the specification, wherein 1) the capture probe is composed of probes as shown in sequences 1 to 113 in a sequence table; 2) the capture probe is composed of derivatives of probes in 1); and the derivative of each probe is a probe which is obtained by substituting and / or deleting and / or adding one or more nucleotides to each probe in 1) and has the same function. According to the deafness-related gene capture kit provided by the invention, target region sequencing analysis is carried out on a whole exon group or a deafness-related genome (respectively accounting for 1% and 0.01% of the whole genome)of a hereditary deafness patient; and most pathogenic mutation information of the disease is captured.
Owner:迈基诺(重庆)基因科技有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products